Sort   by:  
 Page size 
UnknownBRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.
Not available
S-EPMC4356711 | biostudies-literature
UnknownMultimodal contrastive learning for enhanced explainability in pediatric brain tumor molecular diagnosis.
Not available
S-EPMC11955525 | biostudies-literature
UnknownAdolescent and young adult glioma: systematic review of demographic, disease, and treatment influences on survival.
Not available
S-EPMC9721387 | biostudies-literature
UnknownCraniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma.
Not available
S-EPMC6422429 | biostudies-literature
UnknownGenome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility.
Not available
S-EPMC6366343 | biostudies-literature
UnknownImmune Checkpoint Inhibition as Primary Adjuvant Therapy for an IDH1-Mutant Anaplastic Astrocytoma in a Patient with CMMRD: A Case Report-Usage of Immune Checkpoint Inhibition in CMMRD.
Not available
S-EPMC7985791 | biostudies-literature
UnknownClinical and molecular features of disseminated pediatric low-grade glioma and glioneuronal tumors: a systematic review and survival analysis.
Not available
S-EPMC9639355 | biostudies-literature
UnknownMulticlass machine learning models for molecular subtype identification of pediatric low-grade glioma using bi-institutional MRIs for precision medicine
Not available
S-EPMC12624134 | biostudies-literature
UnknownClinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade Glioma.
Not available
S-EPMC8722113 | biostudies-literature
UnknownSegmentation-free pretherapeutic assessment of BRAF-status in pediatric low-grade gliomas.
Not available
S-EPMC12672580 | biostudies-literature
Sort   by:  
 Page size